Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves

被引:328
作者
Olsson, M [1 ]
Thyberg, J
Nilsson, J
机构
[1] Karolinska Hosp, Dept Cardiol, Thorac Clin, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden
[3] Univ Lund, Malmo Univ Hosp, Dept Med, S-22100 Lund, Sweden
关键词
degenerative aortic stenosis; low density lipoprotein; lipid oxidation; T-lymphocyte accumulation;
D O I
10.1161/01.ATV.19.5.1218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to analyze if LDL particles trapped in stenotic aortic valve tissue undergo oxidative modification. Degenerative aortic stenosis affects >3% of the population >75 years of age in the Western world. Recent studies have revealed the presence of a chronic inflammatory process similar to what has been described in other degenerative diseases such as atherosclerosis. However, the underlying disease mechanisms of degenerative aortic stenosis still remain largely unknown. Six tricuspid stenotic valves, obtained at valve replacement, were compared with 3 control valves collected from hearts taken out during transplantation. The stenotic valves and the control valves were examined by immunohistochemistry, using antibodies against apoB, 4-hydroxynonenal-modified LDL, leukocytes, and HLA-DR. All valves were also stained with oil red O for neutral lipids. Extracellular neutral lipids were found in all stenotic valves, extending from the bases along the fibrosa layer; This Lipid colocalized with apoB- and 4-hydroxynonenal-modified LDL immunoreactivity. 4-Hydroxynonenal-modified LDLs were present around calcium deposits, subendothelially, and in the deeper layer of the fibrosa. There was also a colocalization with macrophages, T lymphocytes, and HLA-DR expression. Control valves had a thin area of neutral lipid accumulation, a small amount of apoB, but no signs of inflammation. A distinct colocalization between oxidized LDLs, T-lymphocyte accumulation, and calcium deposits suggests that oxidized lipids may play a role in the disease process.
引用
收藏
页码:1218 / 1222
页数:5
相关论文
共 30 条
[21]  
POMERANCE A, 1967, BRIT HEART J, V29, P222
[22]  
REGNSTROM J, 1994, J LAB CLIN MED, V124, P162
[23]   THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].
ROSS, R .
NATURE, 1993, 362 (6423) :801-809
[24]  
SAKATA N, 1985, Heart and Vessels, V1, P70, DOI 10.1007/BF02066351
[25]  
SEIZER A, 1987, NEW ENGL J MED, V317, P91
[26]  
SELL S, 1965, AM J PATHOL, V46, P345
[27]  
SILVER M, 1991, CARDIOVASC PATHOL, P989
[28]  
STEINBERG D, 1989, NEW ENGL J MED, V320, P915
[29]   ROLE OF OXIDATIVELY MODIFIED LDL IN ATHEROSCLEROSIS [J].
STEINBRECHER, UP ;
ZHANG, HF ;
LOUGHEED, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 9 (02) :155-168
[30]   ROLE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN ATHEROGENESIS [J].
WITZTUM, JL ;
STEINBERG, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1785-1792